FDA Approvals

Date Posted
Article Title
12/31/2008
Nucleic Acid Test Screens for HIV

In donated blood and tissue

12/29/2008
Degarelix Approved for Advanced Prostate Cancer

Suppresses testosterone production

12/22/2008
Zolpimist Approved for Insomnia

Oral spray contains Ambien's active ingredient

12/22/2008
Gleevec Approved for Use After Cancer Surgery

Drug first sanctioned in 2001

12/19/2008
Mozobil Boosts Stem Cells Before Bone Marrow Transplants

Could help people with certain forms of blood cancer

12/16/2008
TriLipix Approved to Help Lower Cholesterol

To be used alone, or in combination with a statin

11/24/2008
Promacta Approved for Rare Blood Disorder

Affects about 60,000 people in United States

11/21/2008
11/12/2008
Early Onset Approved for ADHD Drug

30-minute onset of action for Focalin XR

10/17/2008
Ontak Approved to Treat T-Cell Lymphoma

Targets specific receptor on cancer cells

10/13/2008
NeuroStar Depression Therapy Cleared

Targets nerve cells with magnetic pulses

10/10/2008
Kogenate FS Prevents Joint Damage in Young Hemophiliacs

Hemophilia A affects about 15,000 in the U.S.

10/9/2008
Rapaflo Approved for Enlarged Prostate

The leading reason men visit urologists

9/29/2008
'Superbug' Test Detects MRSA Faster

Existing diagnostics can take up to 3 days

9/18/2008
9/15/2008
9/15/2008
Gardasil Approved for Additional Uses

To help protect women against two more cancers

8/27/2008
New Test Identifies Heart Transplant Rejection

Monitors gene activity in white blood cells

8/22/2008
Bone Marrow Treatment Approved for Rare Bleeding Disorder

Stimulates marrow to compensate for low platelet count

8/15/2008
First Treatment Sanctioned for Chorea in Huntington's Patients

The involuntary jerky movements that accompany the disease